https://turoeducate.turocrates.ai/cases/77d2288c-8e9b-4eaf-be87-cae5ad4cb0c7 please look into this histology and describe the image and give diagnosis

I'll fetch the page and analyze the histology image for you.
Reading Web Page

https://turoeducate.turocrates.ai/cases/77d2288c-8e9b-4eaf-b…

The page requires authentication and couldn't be accessed directly. The URL points to a case on the Turo Educate platform, which is a login-protected system - so I can't retrieve the image from that link.
To help you with the diagnosis, please:
  1. Take a screenshot of the histology image and upload it here, OR
  2. Copy/paste the image directly into the chat
Once I can see the actual histology image, I will:
  • Describe all visible microscopic features (cell types, architecture, staining patterns, any notable findings)
  • Provide a differential diagnosis
  • Give the most likely diagnosis with reasoning
Please share the image directly and I'll give you a full analysis right away.
attachment
attachment
attachment
attachment
attachment
attachment

39 year old female TAH+BSO done for subserous fibroid posterior wall of uterus. Sections from left ovary. This is the question and images

I can see the images clearly. Let me analyze all three with detailed vision analysis while simultaneously consulting the medical library.
analyse_media
analyse_media
analyse_media
Reading File
Now let me search the medical library for ovarian angiosarcoma to correlate with the histological findings.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

angiosarcoma ovary primary histology

Now let me read the key angiosarcoma sections from the textbooks and the recent case report.
Reading File
Reading Article

PMID: 33509230

Reading Article

PMID: 40788747

Now let me read the angiosarcoma section from Robbins for the key histological criteria:
Reading File
I now have all the information needed for a comprehensive analysis. Here is the full report:

Histopathology Report - Left Ovary

Clinical Details: 39-year-old female. TAH+BSO performed for subserous fibroid (posterior wall uterus). Sections from left ovary (incidental/additional finding).

Image Descriptions

Image 1 (Low Power - Whole Section View)
  • The entire tissue section shows a lobulated, nodular architecture replacing normal ovarian parenchyma
  • Large geographic zones of coagulative necrosis dominate the section - vast eosinophilic (pink), acellular, amorphous areas where nuclear detail is lost (karyolysis/karyorrhexis)
  • A prominent large, rounded, thrombosed vessel in the upper-central region shows homogeneous dark-pink material filling the lumen with lines suggesting early organization
  • Between the necrotic zones, there are basophilic cellular bands representing residual viable tumor with hemorrhage
  • Extensive extravasated erythrocytes throughout the tissue
  • Irregular white cleft-like spaces likely represent retraction artifact or areas of liquefactive change
Image 2 (Medium-High Power)
  • Highly atypical cells showing marked pleomorphism - spindle cells, epithelioid cells, and bizarre multinucleated giant cells mixed together
  • Cells are arranged in disorganized, cohesive sheets and dissecting cords that line irregular, blood-filled spaces
  • The most striking feature: highly atypical malignant cells directly lining anastomosing, irregular vascular channels - some cells project into the lumina (vasoformative pattern)
  • Nuclear features: hyperchromatic, coarsely clumped chromatin, large prominent eosinophilic macronucleoli, irregular thickened nuclear membranes
  • Large lakes of extravasated red blood cells dissecting between tumor cells (not contained within well-formed vessels)
  • Fibrocollagenous stroma with areas of myxoid change
  • Scattered lymphocytes and occasional neutrophils in the background
Image 3 (High Power)
  • Marked nuclear atypia with anisokaryosis - extreme variation in nuclear size and shape
  • Bizarre multinucleated tumor giant cells with multiple dark nuclei
  • Atypical mitotic figures including multipolar mitoses - hallmark of high-grade malignancy
  • Some cells show vacuolated cytoplasm with intracytoplasmic lumina occasionally containing trapped erythrocytes - a highly characteristic feature of endothelial differentiation
  • Cytoplasm is moderately abundant, eosinophilic, and glassy in some cells
  • No keratin pearls, no intercellular bridges - squamous differentiation excluded
  • Background of extravasated RBCs and loose collagenous stroma

Diagnosis

Primary Ovarian Angiosarcoma (Epithelioid/High-Grade)


Diagnostic Reasoning

The combination of features is diagnostic:
FeaturePresent in this case
Anastomosing, irregular vascular channelsYes
Malignant endothelial cells lining blood spacesYes
Intracytoplasmic lumina with trapped RBCsYes
Marked nuclear pleomorphism + giant cellsYes
Atypical mitosesYes
Extensive hemorrhage and necrosisYes
Destruction of normal ovarian architectureYes
This pattern - malignant cells forming anastomosing vascular channels and directly lining blood-filled spaces with intracytoplasmic vacuoles containing erythrocytes - is the hallmark of angiosarcoma (malignant endothelial tumor).

Differential Diagnoses (Excluded)

  1. Yolk sac tumor - would show Schiller-Duval bodies, AFP+; no vasoformative pattern
  2. Clear cell carcinoma - hobnail cells, CK/PAX8+; no endothelial lining pattern
  3. Undifferentiated pleomorphic sarcoma / MFH - no vasoformative channels; storiform pattern
  4. Metastatic carcinoma - cohesive glands/nests, epithelial markers positive
  5. Epithelioid hemangioendothelioma - lower grade, myxohyaline stroma, less atypia

Recommended Immunohistochemistry (to confirm)

MarkerExpected in Angiosarcoma
CD31Strongly positive (most sensitive endothelial marker)
ERGPositive
Fli-1Positive
CD34Focally positive
D2-40Can be positive
CK / PAX8Negative (excludes carcinoma)
S-100Negative
Ki-67High (~40-60%)
Per a 2021 case report in J Ovarian Research (PMID: 33509230) and a 2025 Indian J Cancer report (PMID: 40788747), primary ovarian angiosarcoma is exceedingly rare (~1 in 1,000,000 malignant ovarian tumors). It can present as a pure primary tumor or in a background of teratoma/carcinosarcoma. IHC confirmation with CD31, ERG, and Fli-1 positivity with negative epithelial markers is required.

Clinical Significance

  • Primary ovarian angiosarcoma is highly aggressive with poor prognosis
  • Principal metastatic route is hematogenous
  • Requires staging, omentectomy, and pelvic peritoneal assessment
  • Adjuvant treatment options include paclitaxel/carboplatin-based chemotherapy +/- targeted therapy (anti-VEGF) and immunotherapy
  • Multidisciplinary tumor board discussion is essential
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, Vascular Tumors section, p.489
  • Robbins & Kumar Basic Pathology, Tumors chapter
  • Ye H et al., J Ovarian Res 2021 [PMID: 33509230]
  • Kumar A et al., Indian J Cancer 2025 [PMID: 40788747]

This has cytotrophoblast and syncitio trophoblast

Excellent correction - that completely changes the diagnosis. The presence of cytotrophoblasts (mononuclear, polygonal cells with clear cytoplasm and distinct cell borders) and syncytiotrophoblasts (large, multinucleated giant cells with dense eosinophilic cytoplasm) is the key.
Searching sources...
Finding Sources
Finding Sources
Reading File
Reading File
Thank you for that critical correction. With cytotrophoblasts and syncytiotrophoblasts identified, the diagnosis is clear:

Revised Diagnosis: Choriocarcinoma of the Ovary (Non-gestational Germ Cell Type)


Why This Changes Everything

What I initially interpreted as "malignant endothelial cells lining vascular channels" are actually the two defining trophoblastic cell populations:
Cell TypeWhat You See in the Images
CytotrophoblastsMononuclear, polygonal cells with pale/clear cytoplasm, distinct cell membranes, single vesicular nuclei - the "inner" cell layer
SyncytiotrophoblastsLarge, multinucleated giant cells with abundant dense eosinophilic cytoplasm - the bizarre giant cells I noted at high power
This dimorphic trophoblastic pattern - cytotrophoblasts + syncytiotrophoblasts in a background of hemorrhage and necrosis - is the textbook hallmark of choriocarcinoma.

Re-interpreting the Images

Image 1 (Low power):
  • Geographic coagulative necrosis and hemorrhage - classic in choriocarcinoma (tumors often outgrow blood supply)
  • The "thrombosed vessel" = likely a hemorrhagic/necrotic zone
  • Nodular masses of trophoblastic tissue interspersed with blood lakes
Image 2 (Medium-high power):
  • Sheets of cytotrophoblasts (smaller, mononuclear cells) intermingled with
  • Syncytiotrophoblastic giant cells (large, multinucleated) directly bordering hemorrhagic spaces
  • This "lining of blood spaces" by trophoblasts is characteristic - syncytiotrophoblasts physiologically invade vessels
Image 3 (High power):
  • The intracytoplasmic vacuoles = actually cytoplasmic vacuolation of cytotrophoblasts
  • Multinucleated giant cells = syncytiotrophoblasts (NOT tumor giant cells of sarcoma)
  • Marked pleomorphism and atypical mitoses are expected in choriocarcinoma

Classification in This Context

Since this is a 39-year-old female with no history of pregnancy at this site, and this was an ovarian tumor:
Primary Non-gestational Choriocarcinoma of the Ovary (Germ Cell Tumor)
However, given her age and the TAH+BSO context, gestational choriocarcinoma metastatic to the ovary must also be excluded by:
  • Careful history of recent pregnancy/abortion/mole
  • Serum beta-hCG level (will be markedly elevated in both)
  • Histologically both are identical - clinical context distinguishes them
Per Berek & Novak's Gynecology: "Pure nongestational choriocarcinoma of the ovary is extremely rare. Histologically, it has the same appearance as gestational choriocarcinoma metastatic to the ovaries."

Recommended Workup

IHC Panel:
MarkerExpected
beta-hCGStrongly positive in syncytiotrophoblasts
PLAPPositive
CD10Positive in cytotrophoblasts
CK (AE1/AE3)Positive
PAX8Negative
AFPNegative (helps exclude mixed germ cell tumor with yolk sac component)
OCT4 / SALL4May be positive
Serum markers: beta-hCG (markedly elevated), AFP (to rule out mixed germ cell)

Management

  • Staging: CT chest/abdomen/pelvis for metastases (lung, liver, brain are common sites)
  • Chemotherapy: EMA-CO regimen (for gestational) OR BEP (bleomycin, etoposide, cisplatin) for non-gestational germ cell
  • MAC regimen (methotrexate, actinomycin-D, cyclophosphamide) also reported
  • Prognosis: Poor in non-gestational type; gestational choriocarcinoma has far better chemo-sensitivity
  • Monitor: Serial beta-hCG levels as tumor marker for response
  • Berek & Novak's Gynecology, Choriocarcinoma of the Ovary, p.2395
  • Robbins & Kumar Basic Pathology, Table 17.4 - Ovarian Germ Cell Neoplasms, p.699-700

How to distinguish gestational and non gestational

The key distinguishing tool is DNA genotyping - gestational choriocarcinoma contains paternal DNA (it's an allograft), while non-gestational is entirely derived from the patient's own genome. Let me pull the full evidence from the textbooks.
Searching sources...
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

gestational non-gestational choriocarcinoma ovary differentiation diagnosis

Reading File
Reading Article

PMID: 39246853

Reading File
Here is a complete, structured answer:

Distinguishing Gestational vs. Non-Gestational Choriocarcinoma

Histologically, both are identical - both show the same dimorphic cytotrophoblast + syncytiotrophoblast pattern with hemorrhage and necrosis. Distinction depends on clinical, genetic, and ancillary methods.

1. Clinical History (First Step)

FeatureGestationalNon-Gestational
Preceding pregnancyYes - recent molar pregnancy, abortion, ectopic, or term pregnancyNo antecedent pregnancy; or arises de novo
AgeAny reproductive age; often follows moleUsually younger (<20 yrs for pure germ cell); but can be any age
Primary siteUterus most common; ovary = metastasis from uterusOvary is the primary site
Associated tumorUterine/ectopic site identifiedMay arise within teratoma, dysgerminoma, or mixed germ cell tumor
Response to chemoNear 100% remission with methotrexate-based regimens (EMA-CO)Much poorer response; needs BEP (germ cell regimen)

2. The Gold Standard: DNA Genotyping / Short Tandem Repeat (STR) Analysis

This is the most definitive method:
GestationalNon-Gestational
Genetic originContains paternal alleles (it IS a conception product - an allograft in the mother)Only maternal alleles present (purely derived from patient's own genome)
MethodPCR-based STR/microsatellite polymorphism analysis of tumor DNA vs. patient's blood DNASame method
ResultTumor DNA shows extra alleles not present in patient's blood = paternal contribution confirmedTumor DNA is identical to patient's constitutional DNA - no paternal contribution
This is critical because a 39-year-old woman with gestational choriocarcinoma could have had a prior pregnancy/molar pregnancy years ago, and the tumor could represent late recurrence.

3. Morphological Clues (on H&E - not definitive alone)

FeatureGestational (favors)Non-Gestational (favors)
Associated elementsNo other germ cell componentsMay contain teratoma, yolk sac tumor, dysgerminoma
Uterine lesionOften concurrent uterine lesion or scarNo uterine primary
VilliChorionic villi may be present in early casesAbsent (no villous structures)
Intermediate trophoblastMore prominent implantation site intermediate trophoblastLess prominent

4. Immunohistochemistry

MarkerGestationalNon-Gestational
beta-hCGStrongly positive (both)Strongly positive (both)
p57KIP2Negative in complete mole (paternally imprinted gene - absent when no maternal genome)Positive (maternal genome present)
OCT4 / NANOGNegativePositive (germ cell origin)
SALL4NegativePositive
CD10Positive (both)Positive (both)
p57KIP2 and OCT4/SALL4 are the most useful IHC markers to separate the two entities.

5. Serum Markers

  • Beta-hCG is elevated in both - not helpful for distinction
  • However, in gestational type, hCG levels tend to be extremely high and fall rapidly with chemotherapy
  • In non-gestational, hCG may be lower and falls more slowly

Summary Algorithm

Choriocarcinoma on histology
        ↓
History of recent pregnancy / molar disease?
        ↓
YES → Likely Gestational → Confirm with STR genotyping
NO  → Likely Non-Gestational
        ↓
IHC: OCT4/SALL4 positive? → Non-gestational (germ cell origin)
        ↓
STR analysis → Absence of paternal alleles = CONFIRMS Non-gestational

Why This Distinction Matters Critically

GestationalNon-Gestational
Chemo regimenEMA-CO (methotrexate + actinomycin D based)BEP (bleomycin, etoposide, cisplatin)
PrognosisExcellent - ~100% cure rate even with metastasesPoor - aggressive, chemoresistant
FertilityOften preserved after chemoUsually lost (TAH-BSO already done here)
MonitoringSerial beta-hCGSerial beta-hCG + imaging
In this patient's case (39F, TAH-BSO for fibroid, no mention of recent pregnancy), STR genotyping and OCT4/SALL4 IHC should be performed. Given no stated pregnancy history and the ovary being the primary site, non-gestational choriocarcinoma is more likely - but must be confirmed before choosing chemotherapy.
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, Gestational Trophoblastic Disease, p.957-958
  • Berek & Novak's Gynecology, Choriocarcinoma of the Ovary, p.2395
  • Sait HK et al., Cureus 2024 [PMID: 39246853]

Lactational change histology changes

Lactational changes in the breast show secretory acini with vacuolated/hobnail epithelium and intraluminal milk. Let me pull the full textbook details with images.
Searching sources...
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Now let me get the specific microscopic/histological details and fetch the breast diagram image:
Finding Sources
Finding Sources
Finding Sources
Loading Image
Now I have everything needed. Here is the complete answer:

Lactational Changes in the Breast - Histology

Normal Breast Architecture (Reference)

Normal breast structure showing lobules, ducts, luminal and myoepithelial cells
Normally the breast lobule contains acini lined by luminal (blue) cells and myoepithelial (black) cells within intralobular stroma. During lactation, this architecture is profoundly transformed.

Histological Changes - Chronological Sequence

Phase 1: Pregnancy (Proliferative Phase)

FeatureChange
Lobule sizeProgressive increase - lobules enlarge dramatically
Acinar numberMarked increase in acini per lobule (lobulogenesis)
StromaProgressively replaced by expanding lobules - interlobular stroma becomes scant
Myoepithelial cellsBecome flattened and less prominent
Epithelial cellsEnlarged, with increasing secretory activity
Adipose tissueInvolutes as lobules expand
By 3rd monthColostrum-like secretory material visible within acini
Inflammatory cellsMononuclear cell infiltrate in stroma

Phase 2: Active Lactation (Secretory Phase) - KEY HISTOLOGY

This is what you see on H&E:
1. Lobular Expansion
  • Lobules massively enlarged, fill almost the entire breast
  • Acini are greatly increased in number and size
  • Stroma reduced to thin fibrous septae between lobules
2. Acinar Epithelium - Most Characteristic Features
  • Cells are enlarged with abundant, pale/clear or foamy cytoplasm
  • Vacuolated cytoplasm - due to accumulation of lipid droplets (fat globules of milk) in the apical cytoplasm
  • Hobnail appearance - nuclei pushed to the base of the cell by apical lipid vacuoles
  • Snoutlike apical protrusions into the lumen (apocrine-type secretion - secretory caps)
  • Nuclei are basally located, round to oval, with small nucleoli; relatively bland (no significant atypia)
3. Secretory Material in Lumina
  • Acinar lumina are dilated and filled with pale eosinophilic to vacuolated secretion (milk = protein + fat)
  • Lipid droplets visible as clear vacuoles within the lumen
  • Some lumina show granular eosinophilic proteinaceous material (casein)
4. Myoepithelial Cells
  • Compressed, inconspicuous, flattened against basement membrane
  • Still present but difficult to identify on H&E (best seen with SMA IHC)
5. Stroma
  • Markedly reduced - thin fibrous bands between large lobules
  • Edematous and vascular
  • No significant fibrosis

Phase 3: Post-Lactation Involution

FeatureChange
TriggerFall in prolactin on cessation of breastfeeding
Epithelial cellsMassive apoptosis - programmed cell death
Acinar involutionAcini lose lining cells; basement membrane thickens
StromaLoose stroma becomes dense again
LobulesRegress but only partially - permanent changes remain
MicroenvironmentPro-tumorigenic during involution (wound-healing-like state)

Summary: Key Microscopic Features of Lactational Change

FeatureDescription
LobulesMarkedly enlarged, numerous, fill the breast
AciniDilated, lined by enlarged epithelial cells
CytoplasmPale, foamy, vacuolated (lipid droplets)
NucleiBasally placed, bland, no significant atypia
Luminal contentsPale eosinophilic milk secretion + lipid vacuoles
Secretion typeApocrine (apical snout/cap visible)
MyoepitheliumFlattened, inconspicuous
StromaScant, compressed between lobules
Inflammatory cellsMild mononuclear infiltrate

Important Pitfall: Lactational Change vs. Clear Cell Carcinoma

The clear/vacuolated cytoplasm of lactational change can mimic clear cell carcinoma or secretory carcinoma. Key distinguishing features:
Lactational ChangeClear Cell / Secretory Carcinoma
Clinical contextPregnant/breastfeedingNot related to lactation
ArchitecturePreserved lobular units, benign aciniInvasive, irregular nests/sheets
Nuclear atypiaMinimal/blandPresent
MyoepitheliumPresent (flattened)Absent
StromaLoose, normalDesmoplastic
MitosesRareMay be present

Hormonal Basis of the Changes

Estrogen → Ductal proliferation & elongation
Progesterone → Lobule development
Prolactin → Alveolar differentiation, lactogenesis
hCG (early pregnancy) → Corpus luteum support

During lactation:
↓ Progesterone (post-delivery) → removes inhibition → milk production
Prolactin → maintains secretion
Oxytocin → milk let-down (myoepithelial contraction)

Cessation of breastfeeding:
↓ Prolactin → apoptosis → involution
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, Breast Changes in Pregnancy/Lactation, p.961
  • Current Surgical Therapy 14e, Pregnancy Changes to the Breast
  • Creasy & Resnik's Maternal-Fetal Medicine, The Mature Breast
This is a shared conversation. Sign in to Orris to start your own chat.